Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor ...

Merck KGaA expects earnings and sales growth this year after reporting a rise in annual earnings on temporarily reduced ...

Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...

The company has asked the U.S. patent office to reconsider patents that could prevent it from selling an update to Keytruda.

Shares in pharmaceuticals giant Merck (MRK) weakened today on fears that a patent battle could jeopardize its plans to sell a ...

Obesity and pharmacology experts are warning about hidden safety risks and efficacy issues for many types of medications in ...

Merck & Co. Inc. closed 32.72% below its 52-week high of $134.63, which the company achieved on June 25th.

Technology and Consumer Discretionary are the only two sectors down in the first two months of this year, among the 11 market ...

Flu vaccine makers may face a last-minute scramble to produce enough doses after an FDA advisory committee meeting was ...

Fewer precancerous lesions are being found in young women undergoing cervical cancer screenings thanks to the human ...

A new government report says that rates for precancerous lesions decreased about 80% among younger women who were screened ...